Results 1 to 10 of about 403,362 (211)

Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis

open access: yesEJHaem, 2022
Lymphoplasmacytic lymphoma (LPL) and marginal zone lymphoma (MZL) frequently infiltrate the bone marrow with similar histologic and immunohistochemical characteristics posing diagnostic problems.
Mónica García-Cosío
exaly   +3 more sources

Lymphoplasmacytic lymphoma infiltrating both lacrimal glands in a patient with Waldenström's macroglobulinemia

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose To describe a case of Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma with infiltration of both lacrimal glands. Observations A 63-year-old male with Waldenström's macroglobulinemia was referred to the ophthalmological clinic due to ...
Lauge Hjorth Mikkelsen   +1 more
exaly   +4 more sources

Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients. [PDF]

open access: yesChin Med J (Engl), 2023
To the Editor: As a rare indolent B cell non-Hodgkin lymphoma, lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia (LPL/WM) has unique clinical and biological characteristics.[1] However, due to the difficulties in obtaining tumor metaphase for ...
Xiong W   +14 more
europepmc   +2 more sources

Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. [PDF]

open access: yesHemasphere, 2023
Patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) occasionally develop diffuse large B-cell lymphoma (DLBCL). This mostly results from LPL/WM transformation, although clonally unrelated DLBCL can also arise.
Berendsen MR   +15 more
europepmc   +2 more sources

Biclonal lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with POEMS syndrome: A case report and literature review. [PDF]

open access: yesOncol Lett, 2023
Due to its unique clinical, immunological and molecular genetic characteristics, biclonal lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes (POEMS ...
Wang Q, Liu Q, Liang H, Gao W.
europepmc   +2 more sources

Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. [PDF]

open access: yesNat Commun
Lymphoplasmacytic lymphoma (LPL) is an incurable low-grade lymphoma with no standard therapy. Nine asymptomatic patients treated with a first-in-human, neoantigen DNA vaccine experienced no dose limiting toxicities (primary endpoint, NCT01209871).
Szymura SJ   +18 more
europepmc   +2 more sources

Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma

open access: yesScience Advances, 2022
Normal cell counterparts of solid and myeloid tumors accumulate mutations years before disease onset; whether this occurs in B lymphocytes before lymphoma remains uncertain.
S. Rodríguez   +37 more
semanticscholar   +1 more source

Lymphoplasmacytic Lymphoma with Only Lambda Light Chain Monoclonal Paraprotein Expression

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
Introduction Lymphoplasmacytic lymphoma (LPL) is a rare low-grade B-cell neoplasm that accounts for approximately 2% of all haematological malignancies.
Sandhya Cautha   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy